Sabby Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Sabby Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,500	Closed	-$440K	–	216
2021 Q3	$440K	Buy	+3,500	New	+$451K	0.06%	120
2021 Q2	–	Sell	-8,735	Closed	-$1.19M	–	189
2021 Q1	$1.19M	Buy	+8,735	New	+$1.31M	0.23%	73
2020 Q3	–	Sell	-2,150	Closed	-$241K	–	147
2020 Q2	$241K	Buy	+2,150	New	+$212K	0.05%	74
2019 Q1	–	Sell	-62,266	Closed	-$4.47M	–	127
2018 Q4	$4.47M	Buy	+62,266	New	+$5.02M	0.98%	15
2017 Q1	–	Sell	-11,700	Closed	-$693K	–	321
2016 Q4	$693K	Buy	+11,700	New	+$722K	0.04%	170
2014 Q2	–	Sell	-131,235	Closed	-$6.23M	–	291
2014 Q1	$6.23M	Buy	+131,235	New	+$6.72M	0.35%	54

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Sabby Management's XBI Position: Q4 2021 in Review

Sabby Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2021, closing a stake of 3,500 shares — an estimated $440K sold.

Sabby Management first reported a position in XBI in Q1 2014 and held it in 6 quarters. The position peaked at $6.23M in Q1 2014. 702 funds tracked by Wall St. Rank hold XBI as of Q4 2021.

Sabby Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2021 after selling out during the quarter.
Sabby Management sold 3,500 State Street SPDR S&P Biotech ETF shares in Q4 2021, an estimated $440K.
Sabby Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and held it in 6 quarters.
Sabby Management's State Street SPDR S&P Biotech ETF position peaked at $6.23M in Q1 2014.
702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.

Based on Sabby Management's 13F filing for Q4 2021, filed 14 Feb 2022.